1.
Clinical characteristics, treatment, and prognosis of non-B, non-C hepatocellular carcinoma: a large retrospective multicenter cohort study
by Tateishi, Ryosuke
Journal of gastroenterology, 2014-06-15, Vol.50 (3), p.350-360

2.
A randomized controlled trial of lusutrombopag in Japanese patients with chronic liver disease undergoing radiofrequency ablation
by Tateishi, Ryosuke
Journal of gastroenterology, 2018-08-13, Vol.54 (2), p.171-181

3.
Changing etiology of hepatocellular carcinoma
by Tateishi, Ryosuke
Journal of gastroenterology, 2019-08-31, Vol.55 (1), p.125-126

4.
A nationwide survey on non-B, non-C hepatocellular carcinoma in Japan: 2011–2015 update
by Tateishi, Ryosuke
Journal of gastroenterology, 2018-11-29, Vol.54 (4), p.367-376

5.
Mortality and morbidity of hepatectomy, radiofrequency ablation, and embolization for hepatocellular carcinoma: a national survey of 54,145 patients
by Sato, Masaya
Journal of gastroenterology, 2012-03-17, Vol.47 (10), p.1125-1133

6.
Hepatocellular carcinoma as a leading cause of cancer-related deaths in Japanese type 2 diabetes mellitus patients
by Shima, Toshihide
Journal of gastroenterology, 2018-07-13, Vol.54 (1), p.64-77

7.
REFLECT—a phase 3 trial comparing efficacy and safety of lenvatinib to sorafenib for the treatment of unresectable hepatocellular carcinoma: an analysis of Japanese subset
by Yamashita, Tatsuya
Journal of gastroenterology, 2019-11-12, Vol.55 (1), p.113-122

8.
Post-treatment cell-free DNA as a predictive biomarker in molecular-targeted therapy of hepatocellular carcinoma
by Nakatsuka, Takuma
Journal of gastroenterology, 2021-03-12, Vol.56 (5), p.456-469

9.
Hepatic FATP5 expression is associated with histological progression and loss of hepatic fat in NAFLD patients
by Enooku, Kenichiro
Journal of gastroenterology, 2019-10-10, Vol.55 (2), p.227-243

10.
Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma: Japanese subgroup analysis of the REACH trial
by Kudo, Masatoshi
Journal of gastroenterology, 2016-08-22, Vol.52 (4), p.494-503

11.
Hepatic IRS1 and β-catenin expression is associated with histological progression and overt diabetes emergence in NAFLD patients
by Kenichiro Enooku
Journal of gastroenterology, 2018-12-01, Vol.53 (12), p.1261-1275

12.
Artificial intelligence (AI) models for the ultrasonographic diagnosis of liver tumors and comparison of diagnostic accuracies between AI and human experts
by Nishida, Naoshi
Journal of gastroenterology, 2022-02-27, Vol.57 (4), p.309-321

13.
Sofosbuvir plus velpatasvir treatment for hepatitis C virus in patients with decompensated cirrhosis: a Japanese real-world multicenter study
by Tahata, Yuki
Journal of gastroenterology, 2020-10-01, Vol.56 (1), p.67-77

14.
IL28B minor allele is associated with a younger age of onset of hepatocellular carcinoma in patients with chronic hepatitis C virus infection
by Sato, Masaya
Journal of gastroenterology, 2013-05-22, Vol.49 (4), p.748-754

15.
Value of post-vascular phase (Kupffer imaging) by contrast-enhanced ultrasonography using Sonazoid in the detection of hepatocellular carcinoma
by Goto, Eriko
Journal of gastroenterology, 2011-12-27, Vol.47 (4), p.477-485

16.
Liver-related events after direct-acting antiviral therapy in patients with hepatitis C virus-associated cirrhosis
by Tahata, Yuki
Journal of gastroenterology, 2022-01-20, Vol.57 (2), p.120-132

17.
Meta-analysis: mortality and serious adverse events of peginterferon plus ribavirin therapy for chronic hepatitis C
by Minami, Tatsuya
Journal of gastroenterology, 2012-07-12, Vol.48 (2), p.254-268

18.
Hepatic IRS1 and ß-catenin expression is associated with histological progression and overt diabetes emergence in NAFLD patients
by Enooku, Kenichiro
Journal of gastroenterology, 2018-05-10, Vol.53 (12), p.1261-1275

19.
Acute liver disease in Japan: a nationwide analysis of the Japanese Diagnosis Procedure Combination database
by Sato, Masaya
Journal of gastroenterology, 2013-06-20, Vol.49 (3), p.547-554

20.
Perihepatic lymph node enlargement is a negative predictor of liver cancer development in chronic hepatitis C patients
by Hikita, Hiromi
Journal of gastroenterology, 2012-07-12, Vol.48 (3), p.366-373
